Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer [3]

New England Journal of Medicine

Volumn 341, Issue 6, 1999, Pages 452-453

  Swana, H S ^a   Grossman, D ^a   Anthony, J N ^a   Weiss, R M ^a   Altieri, D C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; SURVIVIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AGED; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0033527054     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199908053410614     Document Type: Letter

References (5)